Collaborative Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,069
Closed -$218K 209
2025
Q4
$218K Buy
+2,069
New +$194K 0.08% 217
2024
Q4
Sell
-1,894
Closed -$215K 183
2024
Q3
$215K Buy
1,894
+17
+0.9% +$2.02K 0.1% 163
2024
Q2
$232K Sell
1,877
-22
-1% -$2.83K 0.11% 146
2024
Q1
$251K Hold
1,899
0.13% 138
2023
Q4
$207K Sell
1,899
-410
-18% -$42.6K 0.11% 154
2023
Q3
$238K Buy
2,309
+534
+30% +$57.6K 0.14% 145
2023
Q2
$205K Buy
+1,775
New +$202K 0.12% 157

Other funds holding MRK

Collaborative Wealth Management's MRK Position: Q1 2026 in Review

Collaborative Wealth Management sold out of Merck (MRK) in Q1 2026, closing a stake of 2,069 shares — an estimated $218K sold.

Collaborative Wealth Management first reported a position in MRK in Q2 2023 and held it in 7 quarters. The position peaked at $251K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Collaborative Wealth Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Collaborative Wealth Management sold 2,069 Merck shares in Q1 2026, an estimated $218K.
  • Collaborative Wealth Management first reported a position in Merck in Q2 2023 and held it in 7 quarters.
  • Collaborative Wealth Management's Merck position peaked at $251K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Collaborative Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.